Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat — benefit of combining bisphosphonates with cytostatic agents View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1988-09

AUTHORS

F. Wingen, B. L. Pool, P. Klein, T. Klenner, D. Schmähl

ABSTRACT

This study primarily describes the cytostatic activity of a bisphosphonate and of an alkylating agent linked bisphosphonate toward mammary carcinomas in vivo. Bisphosphonates had been shown to be therapeutically active in bone metastases. There is no animal tumor model available in which both primary mammary carcinomas and bone metastases can be studied simultaneously. Therefore, the Walker carcinosarcoma model, which was used as a model for bone metastasis in earlier studies, was combined with the M-methyl-N-nitrosourea (MNU) induced mammary carcinoma as a model for the primary tumor. Four-, or six-week treatment of MNU-induced mammary carcinomas in Sprague-Dawley rats with the new aromatic bisphosphonate 4[4-[bis(2-chloroethyl)-amino]-phenyl]-1-hydroxybutane-1,1-bisphosphonate (BAD) showed higher antitumor activity than treatment with melphalan or with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) alone. BAD is the APD moiety covalently bound to a molecule derived from melphalan. A combination therapy with 11.75 mg/kg/day APD and 0.6 mg/kg/day melphalan showed the best therapeutic efficacy in this tumor model. In comparison to monotherapy with BAD, APD, or melphalan, a significantly higher rate of complete remissions was achieved. APD, itself, was not genotoxic in 3 employed short term assays. Since bisphosphonates had been shown to be therapeutically active in bone metastases, the antitumor potency of these compounds against experimental primary mammary carcinomas, coupled with the non-genotoxicity of APD and the inhibition of osteolytic bone metastases, might be an important advancement for adjuvant chemotherapy of human mammary carcinomas. More... »

PAGES

155-167

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00175392

DOI

http://dx.doi.org/10.1007/bf00175392

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003893804

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3056867


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diphosphonates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mammary Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melphalan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methylnitrosourea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutagenicity Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitrogen Mustard Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pamidronate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salmonella typhimurium", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wingen", 
        "givenName": "F.", 
        "id": "sg:person.0763271342.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763271342.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pool", 
        "givenName": "B. L.", 
        "id": "sg:person.01073646326.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073646326.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klein", 
        "givenName": "P.", 
        "id": "sg:person.01136305541.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136305541.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klenner", 
        "givenName": "T.", 
        "id": "sg:person.01055432617.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055432617.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schm\u00e4hl", 
        "givenName": "D.", 
        "id": "sg:person.0105462430.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00257217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034528670", 
          "https://doi.org/10.1007/bf00257217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00195363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011532917", 
          "https://doi.org/10.1007/bf00195363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00402773", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011689295", 
          "https://doi.org/10.1007/bf00402773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00389236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033663353", 
          "https://doi.org/10.1007/bf00389236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01985657", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027122062", 
          "https://doi.org/10.1007/bf01985657"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4757-1117-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036156706", 
          "https://doi.org/10.1007/978-1-4757-1117-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1988-09", 
    "datePublishedReg": "1988-09-01", 
    "description": "This study primarily describes the cytostatic activity of a bisphosphonate and of an alkylating agent linked bisphosphonate toward mammary carcinomas in vivo. Bisphosphonates had been shown to be therapeutically active in bone metastases. There is no animal tumor model available in which both primary mammary carcinomas and bone metastases can be studied simultaneously. Therefore, the Walker carcinosarcoma model, which was used as a model for bone metastasis in earlier studies, was combined with the M-methyl-N-nitrosourea (MNU) induced mammary carcinoma as a model for the primary tumor. Four-, or six-week treatment of MNU-induced mammary carcinomas in Sprague-Dawley rats with the new aromatic bisphosphonate 4[4-[bis(2-chloroethyl)-amino]-phenyl]-1-hydroxybutane-1,1-bisphosphonate (BAD) showed higher antitumor activity than treatment with melphalan or with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) alone. BAD is the APD moiety covalently bound to a molecule derived from melphalan. A combination therapy with 11.75 mg/kg/day APD and 0.6 mg/kg/day melphalan showed the best therapeutic efficacy in this tumor model. In comparison to monotherapy with BAD, APD, or melphalan, a significantly higher rate of complete remissions was achieved. APD, itself, was not genotoxic in 3 employed short term assays. Since bisphosphonates had been shown to be therapeutically active in bone metastases, the antitumor potency of these compounds against experimental primary mammary carcinomas, coupled with the non-genotoxicity of APD and the inhibition of osteolytic bone metastases, might be an important advancement for adjuvant chemotherapy of human mammary carcinomas.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00175392", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "bone metastases", 
      "mammary carcinoma", 
      "primary mammary carcinomas", 
      "tumor model", 
      "osteolytic bone metastases", 
      "human mammary carcinoma", 
      "six-week treatment", 
      "animal tumor models", 
      "better therapeutic efficacy", 
      "adjuvant chemotherapy", 
      "complete remission", 
      "combination therapy", 
      "primary tumor", 
      "Sprague-Dawley", 
      "bisphosphonates", 
      "carcinoma", 
      "therapeutic efficacy", 
      "metastasis", 
      "melphalan", 
      "cytostatic agents", 
      "short-term assays", 
      "antitumor activity", 
      "high antitumor activity", 
      "antitumor potency", 
      "cytostatic activity", 
      "high rate", 
      "anticancer activity", 
      "treatment", 
      "APD", 
      "monotherapy", 
      "remission", 
      "chemotherapy", 
      "therapy", 
      "tumors", 
      "agents", 
      "MNU", 
      "activity", 
      "efficacy", 
      "methylnitrosourea", 
      "earlier studies", 
      "vivo", 
      "inhibition", 
      "potency", 
      "bisphosphonic acid", 
      "study", 
      "Bad", 
      "assays", 
      "important advancement", 
      "rate", 
      "acid", 
      "model", 
      "comparison", 
      "advancement", 
      "compounds", 
      "molecules", 
      "moiety"
    ], 
    "name": "Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat \u2014 benefit of combining bisphosphonates with cytostatic agents", 
    "pagination": "155-167", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003893804"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00175392"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3056867"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00175392", 
      "https://app.dimensions.ai/details/publication/pub.1003893804"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_197.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00175392"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00175392'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00175392'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00175392'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00175392'


 

This table displays all metadata directly associated to this object as RDF triples.

221 TRIPLES      21 PREDICATES      101 URIs      87 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00175392 schema:about N089f76fc493947699579f1e8eac66e90
2 N0df325b79eeb427691932e7781014612
3 N39c8c0cb023f4d3a9fb5c31885033d01
4 N44be139a4d894a8eb979840f8120a69f
5 N6e83a30bd3dc4056bf2b21226100e28c
6 N83a65fdaeb624c9dbba29041670a7654
7 N97095ada4c66434d880288a80ebb9030
8 Na09bfd78bd734c0db1e8f7cbf358f691
9 Nd4950b52358745f5870ca87510281e9d
10 Nd49baa31e4e642b7976fd03729a31c0c
11 Ndb43b54f2bb54ec0bbee44fa15212c94
12 Ned66647d2101472bafc900bd9ebb9a20
13 Nf3198a14082c40ff8038b892e244afe0
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N5e91a932b0af454a821923c5bf9f4347
17 schema:citation sg:pub.10.1007/978-1-4757-1117-2
18 sg:pub.10.1007/bf00195363
19 sg:pub.10.1007/bf00257217
20 sg:pub.10.1007/bf00389236
21 sg:pub.10.1007/bf00402773
22 sg:pub.10.1007/bf01985657
23 schema:datePublished 1988-09
24 schema:datePublishedReg 1988-09-01
25 schema:description This study primarily describes the cytostatic activity of a bisphosphonate and of an alkylating agent linked bisphosphonate toward mammary carcinomas in vivo. Bisphosphonates had been shown to be therapeutically active in bone metastases. There is no animal tumor model available in which both primary mammary carcinomas and bone metastases can be studied simultaneously. Therefore, the Walker carcinosarcoma model, which was used as a model for bone metastasis in earlier studies, was combined with the M-methyl-N-nitrosourea (MNU) induced mammary carcinoma as a model for the primary tumor. Four-, or six-week treatment of MNU-induced mammary carcinomas in Sprague-Dawley rats with the new aromatic bisphosphonate 4[4-[bis(2-chloroethyl)-amino]-phenyl]-1-hydroxybutane-1,1-bisphosphonate (BAD) showed higher antitumor activity than treatment with melphalan or with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) alone. BAD is the APD moiety covalently bound to a molecule derived from melphalan. A combination therapy with 11.75 mg/kg/day APD and 0.6 mg/kg/day melphalan showed the best therapeutic efficacy in this tumor model. In comparison to monotherapy with BAD, APD, or melphalan, a significantly higher rate of complete remissions was achieved. APD, itself, was not genotoxic in 3 employed short term assays. Since bisphosphonates had been shown to be therapeutically active in bone metastases, the antitumor potency of these compounds against experimental primary mammary carcinomas, coupled with the non-genotoxicity of APD and the inhibition of osteolytic bone metastases, might be an important advancement for adjuvant chemotherapy of human mammary carcinomas.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N139401cd8708483a99b2e9dd88ab8594
29 N68b4047136cf4889a1403a4eba33b539
30 sg:journal.1094201
31 schema:keywords APD
32 Bad
33 MNU
34 Sprague-Dawley
35 acid
36 activity
37 adjuvant chemotherapy
38 advancement
39 agents
40 animal tumor models
41 anticancer activity
42 antitumor activity
43 antitumor potency
44 assays
45 better therapeutic efficacy
46 bisphosphonates
47 bisphosphonic acid
48 bone metastases
49 carcinoma
50 chemotherapy
51 combination therapy
52 comparison
53 complete remission
54 compounds
55 cytostatic activity
56 cytostatic agents
57 earlier studies
58 efficacy
59 high antitumor activity
60 high rate
61 human mammary carcinoma
62 important advancement
63 inhibition
64 mammary carcinoma
65 melphalan
66 metastasis
67 methylnitrosourea
68 model
69 moiety
70 molecules
71 monotherapy
72 osteolytic bone metastases
73 potency
74 primary mammary carcinomas
75 primary tumor
76 rate
77 remission
78 short-term assays
79 six-week treatment
80 study
81 therapeutic efficacy
82 therapy
83 treatment
84 tumor model
85 tumors
86 vivo
87 schema:name Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat — benefit of combining bisphosphonates with cytostatic agents
88 schema:pagination 155-167
89 schema:productId N7f68ebe084cf49b0adaf83626b5658fc
90 N8c4f7e42165046d6a2bcafe63d90b60e
91 Nc6d135b33b2b40129bdf2d129e27317f
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003893804
93 https://doi.org/10.1007/bf00175392
94 schema:sdDatePublished 2022-12-01T06:19
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher N65c1cf70fb3d4d5897df684a3e6787f4
97 schema:url https://doi.org/10.1007/bf00175392
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N089f76fc493947699579f1e8eac66e90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Mutagenicity Tests
103 rdf:type schema:DefinedTerm
104 N0df325b79eeb427691932e7781014612 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Pamidronate
106 rdf:type schema:DefinedTerm
107 N139401cd8708483a99b2e9dd88ab8594 schema:issueNumber 3
108 rdf:type schema:PublicationIssue
109 N39c8c0cb023f4d3a9fb5c31885033d01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Melphalan
111 rdf:type schema:DefinedTerm
112 N3ddade6294b84d8382cf606c572a20ea rdf:first sg:person.01136305541.39
113 rdf:rest N6be7dc76b1464cb1ade79c07395bc5d5
114 N44be139a4d894a8eb979840f8120a69f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Antineoplastic Combined Chemotherapy Protocols
116 rdf:type schema:DefinedTerm
117 N5e91a932b0af454a821923c5bf9f4347 rdf:first sg:person.0763271342.13
118 rdf:rest Nafbe4d6c78e944149f7e6604a7383339
119 N65c1cf70fb3d4d5897df684a3e6787f4 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 N68b4047136cf4889a1403a4eba33b539 schema:volumeNumber 6
122 rdf:type schema:PublicationVolume
123 N6be7dc76b1464cb1ade79c07395bc5d5 rdf:first sg:person.01055432617.13
124 rdf:rest Nb527ced1fd614fa2956d3859a4f30674
125 N6e83a30bd3dc4056bf2b21226100e28c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Nitrogen Mustard Compounds
127 rdf:type schema:DefinedTerm
128 N7f68ebe084cf49b0adaf83626b5658fc schema:name dimensions_id
129 schema:value pub.1003893804
130 rdf:type schema:PropertyValue
131 N83a65fdaeb624c9dbba29041670a7654 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Rats
133 rdf:type schema:DefinedTerm
134 N8c4f7e42165046d6a2bcafe63d90b60e schema:name doi
135 schema:value 10.1007/bf00175392
136 rdf:type schema:PropertyValue
137 N97095ada4c66434d880288a80ebb9030 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Animals
139 rdf:type schema:DefinedTerm
140 Na09bfd78bd734c0db1e8f7cbf358f691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Mammary Neoplasms, Experimental
142 rdf:type schema:DefinedTerm
143 Nafbe4d6c78e944149f7e6604a7383339 rdf:first sg:person.01073646326.01
144 rdf:rest N3ddade6294b84d8382cf606c572a20ea
145 Nb527ced1fd614fa2956d3859a4f30674 rdf:first sg:person.0105462430.55
146 rdf:rest rdf:nil
147 Nc6d135b33b2b40129bdf2d129e27317f schema:name pubmed_id
148 schema:value 3056867
149 rdf:type schema:PropertyValue
150 Nd4950b52358745f5870ca87510281e9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Methylnitrosourea
152 rdf:type schema:DefinedTerm
153 Nd49baa31e4e642b7976fd03729a31c0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Female
155 rdf:type schema:DefinedTerm
156 Ndb43b54f2bb54ec0bbee44fa15212c94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Rats, Inbred Strains
158 rdf:type schema:DefinedTerm
159 Ned66647d2101472bafc900bd9ebb9a20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Salmonella typhimurium
161 rdf:type schema:DefinedTerm
162 Nf3198a14082c40ff8038b892e244afe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Diphosphonates
164 rdf:type schema:DefinedTerm
165 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
166 schema:name Medical and Health Sciences
167 rdf:type schema:DefinedTerm
168 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
169 schema:name Clinical Sciences
170 rdf:type schema:DefinedTerm
171 sg:journal.1094201 schema:issn 0167-6997
172 1573-0646
173 schema:name Investigational New Drugs
174 schema:publisher Springer Nature
175 rdf:type schema:Periodical
176 sg:person.0105462430.55 schema:affiliation grid-institutes:grid.7497.d
177 schema:familyName Schmähl
178 schema:givenName D.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55
180 rdf:type schema:Person
181 sg:person.01055432617.13 schema:affiliation grid-institutes:grid.7497.d
182 schema:familyName Klenner
183 schema:givenName T.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055432617.13
185 rdf:type schema:Person
186 sg:person.01073646326.01 schema:affiliation grid-institutes:grid.7497.d
187 schema:familyName Pool
188 schema:givenName B. L.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073646326.01
190 rdf:type schema:Person
191 sg:person.01136305541.39 schema:affiliation grid-institutes:grid.7497.d
192 schema:familyName Klein
193 schema:givenName P.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136305541.39
195 rdf:type schema:Person
196 sg:person.0763271342.13 schema:affiliation grid-institutes:grid.7497.d
197 schema:familyName Wingen
198 schema:givenName F.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763271342.13
200 rdf:type schema:Person
201 sg:pub.10.1007/978-1-4757-1117-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036156706
202 https://doi.org/10.1007/978-1-4757-1117-2
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/bf00195363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011532917
205 https://doi.org/10.1007/bf00195363
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/bf00257217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034528670
208 https://doi.org/10.1007/bf00257217
209 rdf:type schema:CreativeWork
210 sg:pub.10.1007/bf00389236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033663353
211 https://doi.org/10.1007/bf00389236
212 rdf:type schema:CreativeWork
213 sg:pub.10.1007/bf00402773 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011689295
214 https://doi.org/10.1007/bf00402773
215 rdf:type schema:CreativeWork
216 sg:pub.10.1007/bf01985657 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027122062
217 https://doi.org/10.1007/bf01985657
218 rdf:type schema:CreativeWork
219 grid-institutes:grid.7497.d schema:alternateName Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG
220 schema:name Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900, Heidelberg, FRG
221 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...